Kprx stock price.

When is Kiora Pharmaceuticals's earnings date? Kiora Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 28th, 2024 based off last year's report dates. Learn more on KPRX's earnings history.Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision. Learn more about our company 355 Alhambra Circle. Suite 801. Coral Gables, Florida 33134. Phone 1 305 420-3200. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023. Revenue $214.2M. Net Income ...In addition to that downgrade, Lai set a price target of $10 per share for XPEV stock. That represents a potential 33.5% downside compared to the stock’s prior closing price.

Kiora Pharmaceuticals, Inc. Common Stock (KPRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.When is Kiora Pharmaceuticals's earnings date? Kiora Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings …

Find the latest TAL Education Group (TAL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Apple Inc (AAPL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Track Kiora Pharmaceuticals Inc (KPRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of …$176.65 UNCH TSLA Tesla, Inc. Common Stock $220.20 +0.24 +0.11% NVDA NVIDIA Corporation Common Stock $450.47 +0.42 +0.09% MSFT Microsoft Corporation Common Stock $352.60 -0.20 -0.06%... We would like to show you a description here but the site won’t allow us.

KPRX’s Market Performance. The stock of Kiora Pharmaceuticals Inc (KPRX) has seen a 11.98% increase in the past week, with a 9.98% rise in the past month, and a 19.87% gain in the past quarter. The volatility ratio for the week is 4.03%, and the volatility levels for the past 30 days are at 5.80% for KPRX. The simple moving average for the ...

Find the latest DermTech, Inc. (DMTK) stock quote, history, news and other vital information to help you with your stock trading and investing.

View live Kiora Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, KPRX financials and market news. 7:08a Clorox’s stock rises on J.P. Morgan upgrade to neutral from underweight 7:07a ‘Too many skunks at the party.’ Bank of America strategist charts S&P 500’s path to 5,000The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32.Find the latest TOP Financial Group Limited (TOP) stock quote, history, news and other vital information to help you with your stock trading and investing.Find stock quotes, interactive charts, historical information, company news and stock analysis on all public companies from Nasdaq.View the latest Prudential Financial Inc. (PRU) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 30, 2023 · Analyst Forecast. According to 3 analysts, the average rating for KPRX stock is "Strong Buy." The 12-month stock price forecast is $41.5, which is an increase of 8,122.71% from the latest price.

The latest price target for Kiora Pharmaceuticals ( NASDAQ: KPRX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 3.50 expecting KPRX to ...Oct 4, 2023 · A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Compare KPRX’s historical performance against its industry peers and the ... Get the latest Fresh Tracks Therapeutics Inc (FRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.KPRX | Complete Kiora Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The public float for KPRX is 6.97M, and at present, short sellers hold a 4.63% of that float. The average trading volume of KPRX on November 23, 2023 was 304.45K shares. KPRX) stock’s latest price update. The stock of Kiora Pharmaceuticals Inc (NASDAQ: KPRX) has decreased by -5.61 when compared to last closing price of 0.56.Despite this, the ...

Virpax Pharmaceuticals (VRPX) said it signed a cooperative research and development agreement ((CRADA)) with the U.S

The public float for KPRX is 6.97M, and at present, short sellers hold a 4.63% of that float. The average trading volume of KPRX on November 23, 2023 was 304.45K shares. KPRX) stock’s latest price update. The stock of Kiora Pharmaceuticals Inc (NASDAQ: KPRX) has decreased by -5.61 when compared to last closing price of 0.56.Despite this, the ...Currently, the analyst consensus on Kiora Pharmaceuticals is a Moderate Buy with an average price target of $2.00. KPRX market cap is currently $3.84M and has a P/E ratio of -0.06. TipRanks has ...Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision. Learn more about our companyThe Kiora Pharmaceuticals, Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of KPRX stock is predicted to rise by 0.82% tomorrow and lose -1.08% in the next 7 days. View the latest Kiora Pharmaceuticals Inc. (KPRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Jul 21, 2023 · The problem with KPRX stock is that its shares have remained below the $1 minimum bid price for 30 consecutive business days. According to this filing, Kiora Pharmaceuticals now has 180 days to ...

Find the latest Enovix Corporation (ENVX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Kiora ended the quarter with $5.4 million in cash and cash equivalents and $1.3 million in tax receivables. Shares +2.34% in after-hours trading after the report. Webull offers KIORA PHARMACEUTICALS INC (KPRX) historical stock prices, in-depth market analysis, NASDAQ: KPRX real-time stock quote data, in-depth charts.

0.20%. $7.78B. Acorda Therapeutics Inc. -1.31%. $11.98M. CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial ... Get the latest NVIDIA Corp (NVDA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Kiora Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time KPRX stock price.Nov 6, 2023 · On November 6, 2023, Kiora Pharmaceuticals Inc (KPRX) experienced a significant increase in its stock performance. The company’s stock price had a median target of $2.00, with a high estimate of $33.00 and a low estimate of $2.00. This median estimate represents a remarkable 221.23% increase from the last recorded price of $0.62. The Kiora Pharmaceuticals, Inc. stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of KPRX stock is predicted to rise by 0.82% tomorrow and lose -1.08% in the next 7 days.Earnings results from Amgen (AMGN), Gilead (GILD) and others are the key highlights from the biotech sector during the past week. Find the latest Kiora Pharmaceuticals, Inc. (KPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Kiora Pharmaceuticals Inc. (NASDAQ: KPRX) stock closed at 0.545 per share at the end of the most recent trading day (a 5.35 % change compared to the prior day closing price) with a volume of 78.73K shares and market capitalization of 4.19M. Is a component of indices and it is traded on NASDAQ exchange.The value each KPRX share was expected to gain vs. the value that each KPRX share actually gained. Kiora Pharmaceuticals ( KPRX) reported Q3 2023 earnings per share (EPS) of -$0.89, missing estimates of -$0.52 by 70.31%. In the same quarter last year, Kiora Pharmaceuticals 's earnings per share (EPS) was -$6.03.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...

Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of ophthalmic diseases. Its pipeline consists of three product candidates, including KIO-101, KIO-301, and KIO-201. Its lead product, KIO-301, is a potential vision-restoring small molecule ...Jul-26-22 04:38PM. Kiora Pharmaceuticals Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option. (Newsfile) Jul-22-22 08:30AM. Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering. (Newsfile) -39.76%.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.The Kiora Pharmaceuticals 52-week high stock price is 8.52, which is 1421.4% above the current share price. The Kiora Pharmaceuticals 52-week low stock price is 0.46, which is 17.9% below the current share price. The average Kiora Pharmaceuticals stock price for the last 52 weeks is 2.18. For more information on how our historical price data is ...Instagram:https://instagram. nvda stock futuresandp and dowcalder mobile for saleusaa mutual funds View the latest Kroger Co. (KR) stock price, news, historical charts, analyst ratings and financial information from WSJ.View the latest Kiora Pharmaceuticals Inc. (KPRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. sanctions venezuelahow to invest 2000 dollars Real time Kiora Pharmaceuticals (EYEG) stock price quote, stock graph, news & analysis ... Price VS S&P. KPRX. Key Data Points. Current Price. The most recent ...355 Alhambra Circle. Suite 801. Coral Gables, Florida 33134. Phone 1 305 420-3200. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023. Revenue $214.2M. Net Income ... best dental insurance in ma Feb 7, 2023 ... ... stock price. Economic Trends and Government Policies. In addition to ... KPRX Stock News. This week's headlines focus on KIO-101 and a related ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.